Is Fresenius publicly traded?

Is Fresenius publicly traded?

Fresenius Medical Care, a publicly traded company of which Fresenius owns 30.8%, focuses on patients with chronic kidney failure. With a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States.